Sartorius (OTCMKTS:SARTF) Sees Large Increase in Short Interest
by Kim Johansen · The Markets DailySartorius (OTCMKTS:SARTF – Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 2,451 shares, an increase of 213.8% from the June 15th total of 781 shares. Based on an average daily trading volume, of 189 shares, the short-interest ratio is presently 13.0 days. Approximately 0.0% of the company’s stock are short sold.
Sartorius Stock Performance
OTCMKTS SARTF opened at $212.80 on Wednesday. Sartorius has a 52 week low of $181.58 and a 52 week high of $227.00. The company has a 50 day moving average price of $211.20 and a 200 day moving average price of $220.47. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89. The firm has a market cap of $7.28 billion, a PE ratio of 98.98 and a beta of 0.98.
Sartorius Company Profile
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.